Annual Congress Amsterdam 2011

Saturday, 24.09.2011
Sunday, 25.09.2011
Monday, 26.09.2011
Tuesday, 27.09.2011
Wednesday, 28.09.2011

Citations should be made in the following way: Authors. Title. Eur Respir J 2011; 38: Suppl. 55, abstract number.

Material from 2011

4205 Abstracts
632 Slide presentations
250 Webcasts
66 Handouts
1703 e-posters
250 Multimedia files

Material from 2011 Show

Treatments for pulmonary hypertension in human and experimental models

Oral Presentation
Chairs: P. Hassoun (Baltimore, United States of America), M. Humbert (Clamart, France)

Download all media

Pharmacological treatment with tetrahydrobiopterin in pulmonary hypertension B. Francis, M. Wilkins, L. Zhao (London, United Kingdom)
A role for ST2/IL-33 signalling in fibroblast proliferation utilising a novel transgenic mouse model of pulmonary hypertension C. Church, A. Mahmood, C. McSharry, D. Xu, A. Peacock, D. Welsh (Glasgow, United Kingdom)
Safety and efficacy of bosentan in combination with sildenafil in pulmonary arterial hypertension: The COMPASS-3 study F. Torres, H. Gupta, F. Soto, M. Park, N. Frey, S. Murali, R. Benza (Dallas, Birmingham, Sheboygan, Baltimore, San Francisco, Pittsburgh, United States Of America)
PDGF and Src tyrosine kinases in pulmonary arterial smooth muscle cells: Effects of dasatinib and nilotinib on pulmonary vascular remodeling S. S. Pullamsetti, E. Burghaüsen, S. Dabral, E. Butrous, A. Tretyn, R. Savai, H. A. Ghofrani, N. Weissmann, F. Grimminger, W. Seeger, S. Rosenkranz, R. T. Schermuly (Bad Nauheim, Giessen, Cologne, Germany; Kent, United Kingdom)
Effects of riociguat in severe experimental pulmonary hypertension B. Kojonazarov, M. Lang, N. Weissmann, F. Grimminger, J. P. Stasch, W. Seeger, H. A. Ghofrani, R. Schermuly (Giessen, Wuppertal, Bad Nauheim, Germany)
Inhibition of microRNA-17 improves lung and heart function in experimental pulmonary hypertension S. Pullamsetti, C. Doebele, A. Fischer, R. Savai, B. Kojonazarov, B. Dahal, H. Ghofrani, N. Weissmann, F. Grimminger, A. Bonauer, W. Seeger, A. Zeiher, S. Dimmeler, R. Schermuly (Bad Nauheim, Frankfurt, Giessen, Germany)
Imatinib in pulmonary arterial hypertension, a randomized, efficacy study (IMPRES) M. Hoeper, R. J. Barst, N. Galié, P. Hassoun, N. Morrell, A. Peacock, G. Simonneau, V. Tapson, F. Torres, K. Lu, D. Quinn, H.A. Ghofrani (Hannover, Giessen, Germany; New York, Baltimore, Durham, Dallas, East Hanover, Cambridge, United States Of America; Bologne, Italy; Cambridge, Glasgow, United Kingdom; Orsay, France)